Literature DB >> 19967552

Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency.

Jan Rohr1, Ulrich Pannicke, Michaela Döring, Annette Schmitt-Graeff, Elisabeth Wiech, Andreas Busch, Carsten Speckmann, Ingo Müller, Peter Lang, Rupert Handgretinger, Paul Fisch, Klaus Schwarz, Stephan Ehl.   

Abstract

INTRODUCTION: We describe a girl presenting at age 6 years with a history of chronic ulcerating intestinal inflammation since 9 months of age. She exhibited a severe, steroid-dependent clinical course of intestinal inflammation over several years in the absence of serious infections. RESULTS AND DISCUSSION: Immunodeficiency was first considered at 6 years of age due to chronic lymphopenia. Immunophenotyping revealed low B and T cell counts with few naïve T cells, a skewed TCR repertoire, and TCR gamma/delta T cell predominance, suggesting a defect of lymphocyte development. Genetic and functional analyses identified a hypomorphic mutation in the DCLRE1C (ARTEMIS) gene compromising V(D)J recombination efficiency, but allowing residual T and B cell development. Hematopoetic stem cell transplantation reconstituted the lymphocyte compartment and cured the inflammatory bowel disease.
CONCLUSION: This report illustrates that a genetic disorder of lymphocyte development can present with chronic inflammatory bowel disease as the dominant phenotype in the absence of severe infection susceptibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19967552     DOI: 10.1007/s10875-009-9349-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  21 in total

1.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

2.  Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.

Authors:  Dietke Buck; Despina Moshous; Régina de Chasseval; Yunmei Ma; Françoise le Deist; Marina Cavazzana-Calvo; Alain Fischer; Jean-Laurent Casanova; Michael R Lieber; Jean-Pierre de Villartay
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

3.  Combined immunodeficiency associated with increased apoptosis of lymphocytes and radiosensitivity fibroblasts.

Authors:  J Peake; A Waugh; F Le Deist; A Priestley; F Rieux-Laucat; N Foray; E Capulas; B K Singleton; J P de Villartay; A Cant; E P Malaise; A Fischer; C Hivroz; P A Jeggo
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

4.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 5.  Genetically determined lymphopenia and autoimmune manifestations.

Authors:  Anna Villa; Veronica Marrella; Francesca Rucci; Luigi D Notarangelo
Journal:  Curr Opin Immunol       Date:  2008-04-09       Impact factor: 7.486

6.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

7.  Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis.

Authors:  Despina Moshous; Christophe Pannetier; Régina de Chasseval Rd; Françoise le Deist Fl; Marina Cavazzana-Calvo; Serge Romana; Elizabeth Macintyre; Danielle Canioni; Nicole Brousse; Alain Fischer; Jean-Laurent Casanova; Jean-Pierre de Villartay
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.

Authors:  Srdjan Pasic; Slavisa Djuricic; Goran Ristic; Bojana Slavkovic
Journal:  Acta Paediatr       Date:  2009-02-24       Impact factor: 2.299

9.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

10.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors:  F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  12 in total

Review 1.  [The gut: center of immunity : Rare inflammatory bowel diseases caused by immunodeficiencies].

Authors:  Carsten Posovszky; Thomas F E Barth
Journal:  Pathologe       Date:  2020-05       Impact factor: 1.011

2.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

Review 3.  Inflammatory bowel disease: is it a primary immunodeficiency?

Authors:  Erik Glocker; Bodo Grimbacher
Journal:  Cell Mol Life Sci       Date:  2011-10-14       Impact factor: 9.261

Review 4.  Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations.

Authors:  Anne E Levine; Hengqi B Zheng; David L Suskind
Journal:  Paediatr Drugs       Date:  2022-04-25       Impact factor: 3.022

Review 5.  Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice.

Authors:  Aline Azabdaftari; Kelsey D J Jones; Jochen Kammermeier; Holm H Uhlig
Journal:  Hum Genet       Date:  2022-06-28       Impact factor: 4.132

6.  Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation.

Authors:  Dhaarini Murugan; Michael H Albert; Jörg Langemeier; Jens Bohne; Jacek Puchalka; Päivi M Järvinen; Fabian Hauck; Anne K Klenk; Christine Prell; Stephanie Schatz; Jana Diestelhorst; Barbara Sciskala; Naschla Kohistani; Bernd H Belohradsky; Susanna Müller; Thomas Kirchner; Mark R Walter; Philip Bufler; Aleixo M Muise; Scott B Snapper; Sibylle Koletzko; Christoph Klein; Daniel Kotlarz
Journal:  J Clin Immunol       Date:  2014-02-12       Impact factor: 8.317

Review 7.  Genetics of inflammatory bowel disease from multifactorial to monogenic forms.

Authors:  Anna Monica Bianco; Martina Girardelli; Alberto Tommasini
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 8.  Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

Authors:  Jodie Ouahed; Elizabeth Spencer; Daniel Kotlarz; Dror S Shouval; Matthew Kowalik; Kaiyue Peng; Michael Field; Leslie Grushkin-Lerner; Sung-Yun Pai; Athos Bousvaros; Judy Cho; Carmen Argmann; Eric Schadt; Dermot P B Mcgovern; Michal Mokry; Edward Nieuwenhuis; Hans Clevers; Fiona Powrie; Holm Uhlig; Christoph Klein; Aleixo Muise; Marla Dubinsky; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2020-05-12       Impact factor: 5.325

9.  A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.

Authors:  Steven Strubbe; Marieke De Bruyne; Ulrich Pannicke; Elien Beyls; Bart Vandekerckhove; Georges Leclercq; Elfride De Baere; Victoria Bordon; Anne Vral; Klaus Schwarz; Filomeen Haerynck; Tom Taghon
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 10.  The diagnostic approach to monogenic very early onset inflammatory bowel disease.

Authors:  Holm H Uhlig; Tobias Schwerd; Sibylle Koletzko; Neil Shah; Jochen Kammermeier; Abdul Elkadri; Jodie Ouahed; David C Wilson; Simon P Travis; Dan Turner; Christoph Klein; Scott B Snapper; Aleixo M Muise
Journal:  Gastroenterology       Date:  2014-07-21       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.